AsiaTides 2010

Fill your pipeline & expand your portfolio with RNAi, aptamer, microRNA, oligonucleotide and peptide based therapeutics

Choose your language

Delivering the Latest Research and Best Practices from Around the World

Conference Tutorials:

• Analysis and Bioanalysis of Oligonucleotides in Support of Drug Development
• RNA/DNA Synthesis and Purification: From Research to Commercial Scale

Conference Sessions:

• RNAi Lead Generation and Preclinical Development
• Updates on Oligo-Based Therapeutics in Clinical and Preclinical Development
• Peptide-Based Therapeutics in Preclinical and Clinical Development
• Peptide Vaccines
• Diagnostics in Development
• Delivery: Challenges and Solutions for Oligo and Peptide Therapeutics
• Market Landscape: Intellectual Property
• Innovation Showcase
• Regulatory Updates

Network with Event More Colleagues:

Co-located with:

• Innovation in Japan - Is It Still Alive?
• Next Generation Biologics
• Personalized Medicine and Biomarker Strategies in Drug Development
• Developments in Stem Cell Science and Therapeutic Applications
• Molecularly Targeted Cancer Therapies as a New Paradigm in Cancer Drug Development

»  More information on this event

Network with Event More Colleagues:

Tides 2010
April 25 - 28, 2010
Boston, MA

»  More information on this event

AsiaTIDES is the only conference in Japan to focus on research, technology and product development, manufacturing and partnering in the field of oligonucleotide- and peptide-based therapeutics and diagnostics. You will hear updates from the most advanced research companies around the world on new approaches to delivery and formulation as well as learn what compounds are currently in development, and what the most successful commercialization strategies are from both the industry and academic perspectives.

Advance your company's research:
• The most advanced companies from North America and European will be presenting their new approaches to delivery and formulation

Benchmark your research and development:
• Find out what other companies are doing, hear case studies and success stories presented by 37 North American and 7 European speakers.

Grow your company's development program and increase your knowledge:
• Participate in sessions on worldwide regulatory expectations, market landscape and partnering ideas

Keynote Presentations:

Synthesis and Biological Activity of the Nucleic Acids and Their Analogs
Marvin H. Caruthers, Ph.D., Distinguished Professor Chemistry and Biochemistry, University of Colorado, USA

Therapeutic Applications of Dicer Substrate siRNAs
John J. Rossi, Ph.D., Chairman, Lidow Family Endowed Research, Professor, Molecular Biology, Beckman Research Institute of City of Hope, USA
Presentation supported by Dicerna Pharmaceuticals

Defying Difficult Diseases: Biomolecule-based Medicinal Science
Yoshiaki Kiso, Ph.D., Professor & Chairman Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Japan

RNAi and Peptide Intellectual Property Landscapes: Early and Evolving
Kathleen M. Williams, Ph.D., J.D. Partner, Intellectual Property Law, Edwards Angell Palmer & Dodge LLP, USA